Novan Inc Valuation

NOVNDelisted Stock  USD 0.03  0.01  33.46%   
Novan seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Novan Inc from analyzing the firm fundamentals such as Profit Margin of (1.29) %, current valuation of 27.74 M, and Return On Equity of -20.99 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
0.03
Please note that Novan's price fluctuation is very steady at this time. Calculation of the real value of Novan Inc is based on 3 months time horizon. Increasing Novan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Novan Inc is useful when determining the fair value of the Novan stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Novan. Since Novan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Novan Stock. However, Novan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0347 Real  0.033 Hype  0.03 Naive  0.13
The real value of Novan Stock, also known as its intrinsic value, is the underlying worth of Novan Inc Company, which is reflected in its stock price. It is based on Novan's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Novan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Novan's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.03
Real Value
0.04
Upside
Estimating the potential upside or downside of Novan Inc helps investors to forecast how Novan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Novan more accurately as focusing exclusively on Novan's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.030.03
Details
Hype
Prediction
LowEstimatedHigh
0.030.030.04
Details
Naive
Forecast
LowNext ValueHigh
0.130.130.13
Details

Novan Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Novan's current stock value. Our valuation model uses many indicators to compare Novan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novan competition to find correlations between indicators driving Novan's intrinsic value. More Info.
Novan Inc is rated below average in price to earning category among related companies. It is regarded fifth in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Novan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Novan's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novan's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Novan's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Novan and how it compares across the competition.

About Novan Valuation

The delisted stock valuation mechanism determines the current worth of Novan Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Novan Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Novan Inc based exclusively on its fundamental and basic technical indicators. By analyzing Novan's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Novan's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novan. We calculate exposure to Novan's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novan's related companies.
Novan, Inc., a medical dermatology company, focuses on researching, developing, and commercializing therapeutic products for skin diseases. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Novan operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

8 Steps to conduct Novan's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Novan's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Novan's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Novan's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Novan's revenue streams: Identify Novan's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Novan's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Novan's growth potential: Evaluate Novan's management, business model, and growth potential.
  • Determine Novan's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Novan's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Novan Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Novan does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding22 M
Quarterly Earnings Growth Y O Y-0.615
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Novan Stock

If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope